Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros











Intervalo de año de publicación
1.
DNA Repair (Amst) ; 37: 43-52, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26687588

RESUMEN

Exposure to polycyclic aromatic hydrocarbon (PAH) environmental contaminants has been associated with the development of mutations and cancer. 7,12-Dimethylbenz(a)anthracene ( DMBA), a genotoxic agent, reacts with DNA directly, inducing p53-dependent cytotoxicity resulting in cell death by apoptosis or giving rise to cancer. DMBA metabolism largely depends on activation of the aryl hydrocarbon receptor (AhR). Mice phenotypically selected for high (AIRmax) or low (AIRmin) acute inflammatory response present a complete segregation of Ahr alleles endowed with low (Ahr(d)) or high (Ahr(b1)) affinity to PAHs, respectively. To evaluate the role of AhR genetic polymorphism on the bone marrow susceptibility to DMBA, AIRmax and AIRmin mice were treated with a single intraperitoneal injection of DMBA (50mg/kg b.w.) in olive oil. Bone marrow cells (BMCs) were phenotyped by both flow cytometry and cytoslide preparations. Despite a significant decrease in total cell count in BM from AIRmin mice, there was an increase of blast cells and immature neutrophils at 1 and 50 days after DMBA treatment, probably due to a cell-cycle blockade at the G1/S transition leading to immature stage cell production. A panel of proteins related to cell cycle regulation was evaluated in immature BM cells (Lin(-)) by Western Blot, and DNA damage and repair were measured using an alkaline version of the Comet assay. In Lin(-) cells isolated from AIRmin mice, high levels were found in both p53 and p21 protein contents in contrast with the low levels of CDK4 and Ciclin D1. Evaluation of DNA repair in DMBA-treated BMCs, indicated long-lasting genotoxicity and cytotoxicity in BMC from AIRmin mice and a blockade of cell cycle progression. On the other hand, AIRmax mice have a high capacity of DNA damage repair and protection. These mechanisms can be associated with the differential susceptibility to the toxic and carcinogenic effects of DMBA observed in these mice.


Asunto(s)
9,10-Dimetil-1,2-benzantraceno/farmacología , Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico/genética , Células de la Médula Ósea/efectos de los fármacos , Daño del ADN , Contaminantes Ambientales/toxicidad , Mutágenos/toxicidad , Receptores de Hidrocarburo de Aril/genética , 9,10-Dimetil-1,2-benzantraceno/metabolismo , Animales , Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico/metabolismo , Ensayo Cometa , ADN/efectos de los fármacos , Reparación del ADN/genética , Citometría de Flujo , Inflamación/genética , Masculino , Ratones , Polimorfismo Genético , Receptores de Hidrocarburo de Aril/metabolismo
2.
Biomed Res Int ; 2013: 618475, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24199196

RESUMEN

Gap junctions are communicating junctions which are important for tissue homeostasis, and their disruption is involved in carcinogenic processes. This study aimed to verify the influence of deletion of one allele of the Connexin 43 gene on cancer incidence in different organs. The 7, 12-dimethylbenzanthracene (DMBA) carcinogenic model, using hebdomadary doses by gavage of 9 mg per animal, was used to induce tumors in Connexin 43 heterozygous or wild-type mice. The experiment began in the eighth week of the mice life, and all of them were euthanized when reaching inadequate physical condition, or at the end of 53 weeks. No statistical differences occurred for weight gain and cancer survival time (P = 0.9853) between heterozygous and wild-type mice. Cx43⁺/⁻ mice presented significantly higher susceptibility to lung cancer (P = 0.0200) which was not evidenced for benign neoplasms (P = 0.3449). In addition, incidence of ovarian neoplasms was 2.5-fold higher in Cx43⁺/⁻ mice, although not statistically significant. Other organs showed a very similar cancer occurrence between Cx43 groups. The experiment strengthens the evidence of the relationship between Connexin 43 deficiency and carcinogenesis.


Asunto(s)
Adenocarcinoma/metabolismo , Transformación Celular Neoplásica/metabolismo , Conexina 43 , Neoplasias Pulmonares/metabolismo , Neoplasias Experimentales/metabolismo , 9,10-Dimetil-1,2-benzantraceno/efectos adversos , 9,10-Dimetil-1,2-benzantraceno/farmacología , Adenocarcinoma/inducido químicamente , Adenocarcinoma/genética , Adenocarcinoma/patología , Animales , Carcinógenos/toxicidad , Transformación Celular Neoplásica/inducido químicamente , Transformación Celular Neoplásica/genética , Transformación Celular Neoplásica/patología , Neoplasias Pulmonares/inducido químicamente , Neoplasias Pulmonares/genética , Neoplasias Pulmonares/patología , Ratones , Ratones Noqueados , Neoplasias Experimentales/inducido químicamente , Neoplasias Experimentales/genética , Neoplasias Experimentales/patología
3.
Med Oral Patol Oral Cir Bucal ; 18(2): e325-31, 2013 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-23229248

RESUMEN

OBJECTIVE: [corrected] The aim of this study was to determine erbB expression in normal mucosa, oral dysplasia, and invasive carcinomas developed in the hamster's buccal pouch chemical carcinogenesis model. STUDY DESIGN: Fifty Syrian golden hamsters were equally divided in five groups (A-E); two controls and three experimental group exposed to alcohol, DMBA, or both for 14 weeks. Number of tumors per cheek, volume, histological condition, erbB expression were determined and results were analyzed by the Mann-Whitney U and Dunn's test. RESULTS: Control groups and those exposed to alcohol (A, B and C respectively) only presented clinical and histological normal mucosa; while those exposed to DMBA or DMBA plus alcohol (D and E groups) developed dysplasia and invasive carcinomas. erbB2, erbB3, and erbB4 increased their expression in alcohol-exposed mucosa, dysplasia, and invasive carcinomas. We observed a similar expression level for erbB2 in dysplasia and carcinomas; while, erbB3 and erbB4 were similar only in carcinomas. CONCLUSION: The DMBA and alcohol can be considered as carcinogen and promoter for oral carcinogenesis. The erbB expression is different according to their histological condition, suggesting differential participation of the erbB family in oral carcinogenesis induced by alcohol and DMBA.


Asunto(s)
9,10-Dimetil-1,2-benzantraceno/farmacología , Carcinoma de Células Escamosas/genética , Etanol/farmacología , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Genes erbB/genética , Neoplasias de la Boca/genética , Neoplasias Experimentales/genética , 9,10-Dimetil-1,2-benzantraceno/administración & dosificación , Animales , Carcinógenos/administración & dosificación , Carcinoma de Células Escamosas/inducido químicamente , Cricetinae , Masculino , Neoplasias de la Boca/inducido químicamente , Neoplasias Experimentales/inducido químicamente
4.
Biomedica ; 32(3): 437-48, 2012 Sep.
Artículo en Español | MEDLINE | ID: mdl-23715192

RESUMEN

INTRODUCTION: Mutagens contained in complex mixtures can present synergistic interactions, either additive or antagonistic. Therefore, development of experimental approaches is necessary to elucidate which is the responsible agent for the effect in the mixtures. OBJECTIVE: An experimental design was developed that allowed an understanding of the processes between the compounds of complex mixtures. MATERIALS AND METHODS: Human lymphocytes were exposed to binary mixtures of the mutagens B[a]P, DMBA, Trp-P-1 and MX for 1 hour with or without S9. Viability was assessed with trypan blue dye and the genotoxicity by the comet assay. RESULTS: All of the hydrocarbon showed an effect with furanone. With and without S9, the most toxic interactions were observed between hydrocarbons. Synergistic interaction was observed without S9 between B [a] P and Trp-P-1 and between DMBA and Trp-P-1 with metabolic activity. Without S9 antagonistic interaction was observed only between Trp-P-1+DMBA, and with S9 between Trp-P-1+MX and MX+DMBA. It observed an increase dose dependent in tail length. Half the cultures showed genotoxic damage and increased cell damage. For each mixture, minimum concentrations were determined at which adverse effects are observed; for some only the maximum concentration was determined at which no adverse effects are observed. CONCLUSION: The processes between mutagens present in a mixture have become better understood, and the results validated an analytical model that determined which component had an effect on another. The results also showed that the type of compounds in the mixture determined whether or not a risk threshold was present.


Asunto(s)
Ensayo Cometa , Linfocitos/efectos de los fármacos , Mutágenos/toxicidad , 9,10-Dimetil-1,2-benzantraceno/administración & dosificación , 9,10-Dimetil-1,2-benzantraceno/farmacología , 9,10-Dimetil-1,2-benzantraceno/toxicidad , Adulto , Benzo(a)pireno/administración & dosificación , Benzo(a)pireno/farmacología , Benzo(a)pireno/toxicidad , Biotransformación , Carbolinas/administración & dosificación , Carbolinas/farmacología , Carbolinas/toxicidad , Supervivencia Celular , Células Cultivadas/efectos de los fármacos , Células Cultivadas/ultraestructura , Daño del ADN , Interacciones Farmacológicas , Furanos/administración & dosificación , Furanos/farmacología , Furanos/toxicidad , Humanos , Técnicas In Vitro , Concentración 50 Inhibidora , Linfocitos/ultraestructura , Masculino , Microsomas Hepáticos/metabolismo , Mutágenos/administración & dosificación , Mutágenos/farmacología
6.
Bauru; s.n; 1999. 116 p. ilus. (BR).
Tesis en Portugués | LILACS, BBO - Odontología | ID: lil-298434

RESUMEN

Estudou-se de forma comparativa, os efeitos de peróxido de hidrogênio sobre a mucosa bucal de hamsters. Utilizou-se 96 animais, divididos em 8 grupos, aplicando-se: água destilada; DMBA; peróxido de carbamida a 10 por cento com carbopol; peróxido de hidrogênio a 27 por cento; dentifrício com peróxido de hidrogênio; DMBA+peróxido de carbamida a 10 por cento com carbopol; DMBA+peróxido de hidrogênio a vinte e sete por cento; DMBA+dentifrício com peróxido de hidrogênio. Pode-se constatar que o peróxido de hidrogênio, nas várias formas aplicadas, näo induziu alteraçöes epiteliais de nenhuma natureza e morfologicamente detectáveis à microscopia óptica de luz. Os mesmos produtos, aplicados após o DMBA, aumentaram o número de animais mais severamente comprometidos e promoveram lesöes carcinomatosas mais amplas e severas na mucosa, quer seja do ponto de vista macro ou microscópico. Concluiu-se que o peróxido de hidrogênio atua como agente promotor da carcinogênese, pois potencializa o efeito de agentes iniciadores na carcinogênese bucal química


Asunto(s)
Animales , Masculino , Femenino , Lactante , Cricetinae , Mucosa Bucal/efectos de los fármacos , Peróxido de Hidrógeno/farmacología , 9,10-Dimetil-1,2-benzantraceno/farmacología , Carcinógenos/clasificación , Carcinógenos/farmacología , Dentífricos/farmacología , Agua Destilada , Patología Bucal , Peróxidos/clasificación , Peróxidos/farmacología
7.
Rev. bras. cancerol ; 37(1/4): 33-6, jan.-dez. 1991. tab, graf
Artículo en Inglés | LILACS | ID: lil-157804

RESUMEN

Cinco modelos de estudo (A,B,C,D,E) foram usados para investigar o efeito do 7,12-dimetilbenz(a)antraceno em induzir tumores no tecido mamário de ratas Sprague-Dawley. Cada grupo foi submetido ad libitum às seguintes dietas: grupo A - raçäo comercial ; grupos B e C - uma dieta semipurificada rica em ácido linóico; grupo D - uma dieta semipurificada rica em ácido graxo saturado; grupo E - uma dieta gordurosa de 50 porcento de óleo de soja (rico em ácido graxo essencial), 25 porcento de óleo de oliva (rico em ácido oleico) e 25 porcento de óleo de coco (rico em ácido graxo saturado). Os grupos A,B,C,D e E desenvolveram 52 porcento, 76 porcento, 88 porcento, 60 porcento e 67 porcento de tumores, respectivamente. Nos grupos testes A,B,C,D e E, o primeiro tumor palpável foi visto 200 a 52, 103 a 36, 48 a 1, 133 a 62 e 183 a 45 dias após a administraçäo do DMBA, respectivamente. 14,8 porcento, 97,5 porcento e 41,7 porcento de todos os tumores foram classificados como adenocarcinomas. Os resultados sugerem que o modelo de estudo C foi o mais efetivo, induzindo, o maior, incidência de adenocarcinomas nos ratos tratados por DMBA, os sintomas foram evidentes no menor tempo experimental.


Asunto(s)
Animales , Femenino , Ratas , 9,10-Dimetil-1,2-benzantraceno/farmacología , Neoplasias de la Mama/inducido químicamente , Modelos Animales de Enfermedad , Ratas Sprague-Dawley
8.
Carcinogenesis ; 12(11): 2047-52, 1991 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-1934290

RESUMEN

The oxidative stress induced in vivo by benzoyl peroxide (BzPo) or 12-O-tetradecanoylphorbol-13-acetate (TPA) was evaluated in terms of chemiluminescence (CL) emitted by SENCAR mouse skin, a non-invasive method that allows an estimation of overall oxidative stress. The ability of a biomimetic superoxide dismutase, copper(II)(3,5-diisopropylsalicylate)2 (CuDIPS), to inhibit that response was also evaluated. A single application of BzPo to mouse skin resulted in a dose-dependent increase in CL up to 0.083 mumol. Sequential treatment with BzPo in a dose used for tumor promotion resulted in a fall in CL induced by the second topical application. There were no differences between initiated and non-initiated mice in their responses to BzPo-induced CL. CuDIPS, an inhibitor of tumor promotion, was an effective inhibitor of CL in all the protocols evaluated. Conversely, ZnDIPS and DIPS did not inhibit CL. Phenolic antioxidants induced partial inhibition of CL. Unlike BzPo treatment, a single application of TPA up to 105 nmol did not induce an increase in CL, but the second topical application with TPA in a dose used for tumor promotion resulted in a small but significant increase in CL. However, these values of CL were much smaller than the CL induced by BzPo. Our results show a differential response of the skin in terms of the oxidative stress induced by BzPo or TPA.


Asunto(s)
Peróxido de Benzoílo/farmacología , Oxidación-Reducción , Piel/metabolismo , Acetato de Tetradecanoilforbol/farmacología , 9,10-Dimetil-1,2-benzantraceno/farmacología , Animales , Antineoplásicos/farmacología , Hidroxianisol Butilado/farmacología , Hidroxitolueno Butilado/farmacología , Mediciones Luminiscentes , Ratones , Ratones Endogámicos , Salicilatos/farmacología , Piel/efectos de los fármacos
9.
Biomed Pharmacother ; 45(1): 15-22, 1991.
Artículo en Inglés | MEDLINE | ID: mdl-1904282

RESUMEN

Prolactin receptor and IGF1 gene expression were measured in mammary glands from Sprague-Dawley rats at different times (10, 30; and 58 d) after administration of a single dose of 15 mg dimethylbenz(a)-anthracene (DMBA) per os at 55 d of age, and in DMBA-induced mammary tumors appearing in these rats at approximately 2 months after DMBA administration; The relative gene expression of prolactin receptor and insulin-like growth factor (IGF1) mRNAs was measured by hybridization to Northern blots prepared from pools of tissue. The probes used were 32P-labelled cDNAs specific to the extracellular domain of the receptor (E probe), common to all forms, and a probe specific to the intracellular position of the long form of the receptor (I probe), a human IGF1 probe, and chicken beta-actin probe, to correct for loss of tissue and different metabolic activity of the tissues. Hybridization with the prolactin receptor probes revealed bands at 2.5, 3; and 5.5 kb hybridizing with the long form of the receptor and a more intense band at 1.8 kb that corresponded to the short form of the receptor. There were no changes in the relative expression of prolactin receptor mRNAs in the mammary gland of control (oil-treated) or DMBA-treated rats, although there was a gradual diminution of expression with increasing age of the animals. In contrast, in DMBA-induced mammary tumors, there was a marked increase in the relative expression of prolactin receptor mRNAs with, however, no modification in the relative proportion of short and long forms.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
9,10-Dimetil-1,2-benzantraceno/farmacología , Expresión Génica/efectos de los fármacos , Factor I del Crecimiento Similar a la Insulina/genética , Glándulas Mamarias Animales/química , Receptor de Insulina/genética , Receptores de Prolactina/genética , Factores de Edad , Animales , Northern Blotting , Femenino , Neoplasias Mamarias Experimentales/genética , Ratas , Ratas Endogámicas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA